| Bid Price | 10182.00p | High Price | 10202.00p |
|---|
| Ask Price | 10184.00p | Low Price | 10048.00p |
|---|
| Open Price | 10152.00p | Spread | 0.02% |
|---|
| Prev Close | 10254.00p | Volume | 3,270,915 |
|---|
Astrazeneca PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Apr 17, 2025 | 10152.00 | 10202.00 | 10048.00 | 10124.00 | 3,270,915 |
| Apr 16, 2025 | 10280.00 | 10322.00 | 10154.00 | 10254.00 | 1,901,968 |
| Apr 15, 2025 | 10260.00 | 10336.00 | 10198.00 | 10280.00 | 3,745,275 |
| Apr 14, 2025 | 10190.00 | 10332.00 | 10120.00 | 10320.00 | 1,379,564 |
Astrazeneca PLC Information
| Name | Astrazeneca PLC | Index | FTSE 100 |
|---|
| ISIN | GB0009895292 | Epic | AZN |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | SET1 |
|---|
| Industry | Drug Manufacturers - General | Sector | Healthcare |
|---|
| EMS | 150 | Trading Status | Closed |
|---|
| Shares in Issue | 1.55 bn | Prev Close | 10254.00p |
|---|
| PE Ratio | 29.769046 | Market Cap | £156.94 bn |
|---|
| Div Yield | 2.43 | Div per Share | $0.00 |
|---|
| EPS | $0.96 | Div Cover | NaN |
|---|
| PEG | 0.9547 | EPS Growth (%) | 0.00 |
|---|
| ROCE | 0.022607 | DPS Growth (%) | 0.0409 |
|---|
| Current Ratio | 0.93169 | Quick Ratio | 0.648345 |
|---|
Astrazeneca PLC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 07/03/25 | TIN | Pascal Soriot | CEO | 89,962 @ £0.00 | £0.00 |
| 06/03/25 | DRIP | Pascal Soriot | CEO | 248 @ £0.00 | £0.00 |
| 06/03/25 | TIN | Pascal Soriot | CEO | 17,357 @ £0.00 | £0.00 |
| 06/03/25 | DRIP | Aradhana Sarin | FD | 28 @ £0.00 | £0.00 |
| 06/03/25 | TIN | Aradhana Sarin | FD | 2,021 @ £0.00 | £0.00 |
| 20/11/24 | BUY | Tony Mok | NED | 1,500 @ $126.80 | $190,195.00 |
| 15/11/24 | BUY | Pascal Soriot | CEO | 20,000 @ £102.03 | £2,040,600.00 |
| 15/11/24 | BUY | Michel Demare | NED | 2,000 @ £100.30 | £200,607.00 |
| 13/11/24 | BUY | Philip Broadley | NED | 980 @ £101.70 | £99,665.00 |
| 13/09/24 | BUY | Michel Demare | NED | 2,000 @ £117.93 | £235,855.00 |
Astrazeneca PLC News
